Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population?

Efficacy and safety of olaparib monotherapy in germline BRCA1 / 2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy

(2016) Susan M. Domchek et al.   GYNECOLOGIC ONCOLOGY

BRCA1andBRCA2genetic testing—pitfalls and recommendations for managing variants of uncertain clinical significance

(2015) D. M. Eccles et al.   ANNALS OF ONCOLOGY

Deleterious BRCA1/2 mutations in an urban population of Black women

(2015) Filipa Lynce et al.   BREAST CANCER RESEARCH AND TREATMENT

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A high frequency ofBRCAmutations in young black women with breast cancer residing in Florida

(2015) Tuya Pal et al.   CANCER

Concerns About Cancer Risk and Experiences With Genetic Testing in a Diverse Population of Patients With Breast Cancer

(2015) Reshma Jagsi et al.   JOURNAL OF CLINICAL ONCOLOGY

Multiple Barriers Delay Care Among Women with Abnormal Cancer Screening Despite Patient Navigation

(2015) Ambili Ramachandran et al.   JOURNAL OF WOMENS HEALTH

Patient Navigation to Improve Follow-Up of Abnormal Mammograms Among Disadvantaged Women

(2015) Sanja Percac-Lima et al.   JOURNAL OF WOMENS HEALTH

A Randomized, Controlled Trial to Increase Discussion of Breast Cancer in Primary Care

(2014) C. P. Kaplan et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Bridging The Gap: A Community Health Program Saved Lives, Then Closed Its Doors

(2014) Heidi L. Behforouz   HEALTH AFFAIRS

American BRCA Outcomes and Utilization of Testing (ABOUT) Study: A Pragmatic Research Model that Incorporates Personalized Medicine/Patient-Centered Outcomes in a Real World Setting

(2014) Joanne Armstrong et al.   Journal of Genetic Counseling

Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers

(2014) Claudia Marchetti et al.   BMC Womens Health

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation

(2013) Heidi D. Nelson et al.   ANNALS OF INTERNAL MEDICINE

Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk

(2011) Douglas E Levy et al.   GENETICS IN MEDICINE

Effect of Screening on Ovarian Cancer Mortality

(2011) Saundra S. Buys   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Serous Tubal Intraepithelial Carcinoma: Diagnostic Reproducibility and its Implications

(2010) Joseph W. Carlson et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

(2010) Susan M. Domchek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Patient Navigation: The Promise to Reduce Health Disparities

(2010) Karen M. Freund   JOURNAL OF GENERAL INTERNAL MEDICINE

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

(2010) M William Audeh et al.   LANCET

Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: A fundamental cause of disease approach

(2010) Seijeoung Kim et al.   SOCIAL SCIENCE & MEDICINE

Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups

(2009) B. G. Haffty et al.   ANNALS OF ONCOLOGY

BRCA1andBRCA2mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer

(2009) Michael J. Hall et al.   CANCER

Addressing Social Determinants of Health to Improve Access to Early Breast Cancer Detection: Results of the Boston REACH 2010 Breast and Cervical Cancer Coalition Women's Health Demonstration Project

(2009) Cheryl R. Clark et al.   JOURNAL OF WOMENS HEALTH

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers

(2008) Kelly A. Metcalfe et al.   INTERNATIONAL JOURNAL OF CANCER

“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations

(2008) David S.P. Tan et al.   JOURNAL OF CLINICAL ONCOLOGY

Increased Uptake of BRCA1/2 Genetic Testing Among African American Women With a Recent Diagnosis of Breast Cancer

(2007) Lisa R. Susswein et al.   JOURNAL OF CLINICAL ONCOLOGY